The Proanthocyanidins markethas witnessed remarkable growth in recent years, driven by increasing awareness of the potential health benefits these natural compounds offer. Proanth ...
The product's appeal lies in its simplicity: a mix of natural ingredients, non-GMO, and manufactured in the USA in an FDA-approved and GMP-certified facility. The product also claims to be free of ...
A study by the University of Exeter and Maastricht University published in JAMA Neurology has identified some of risk factors that can lead to early cases of dementia ― some of which may surprise you.
A report predicts the launch of six late-stage pipeline drugs during this period. The glaucoma market across the seven major markets (7MM) is projected to reach $2.5b by 2033 at a compound annual ...